Correction

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

N Engl J Med 1996; 334:1070April 18, 1996

Article

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer (Original Article, N Engl J Med 1996:334;1 - 6) . On page 1, in the Results paragraph of the Abstract, the fourth sentence should have read, “Among 216 women with measurable disease, 51 percent of the cisplatin–paclitaxel group had a complete response to therapy and 22 percent a partial response, whereas 31 percent of the cisplatin–cyclophosphamide group had a complete response and 29 percent a partial response (P = 0.01, ξ² ₂ = 8.97).”